The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.

Mol Cancer · 2013 · PMC3669624 · PMID 23705854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the primary endpoint (time to recurrence) did not reach statistical significance, the results support a beneficial effect of celecoxib in such patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.